Find clinical trials for Multiple Sclerosis (MS) in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near San Francisco, CA, USA:
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Palo Alto, California, United States and 18 other locations
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects with Refractory Primary and Secondary Progressive Multiple...
Phase 2
Palo Alto, California, United States
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP...
Phase 1, Phase 2
San Francisco, California, United States and 2 other locations
This is an open label, Phase 1b, multiple ascending dose, and dose-expansion study of IDP-023 administered in combination with interleukin-2 ...
Phase 1
San Francisco, California, United States and 3 other locations
Newly diagnosed relapsing multiple sclerosis (MS) and high risk clinically isolated syndrome (CIS) patients will be treate...
Phase 4
San Francisco, California, United States
This study will evaluate whether ofatumumab is excreted at quantifiable levels and at which concentrations in breast milk of lactating women with RMS...
Phase 4
San Francisco, California, United States and 2 other locations
B cell-depleting therapies, such as ocrelizumab, are among the most effective medications currently available for the treatment of multiple ...
Phase 4
San Francisco, California, United States
In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...
Phase 2
Berkeley, California, United States and 76 other locations
A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects with Non-relapsing and Progressive Forms of Multiple Sclerosis...
Phase 1
Palo Alto, California, United States
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
San Francisco, California, United States and 107 other locations
Clinical trials
Research sites
Resources
Legal